Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 30:14:1270472.
doi: 10.3389/fendo.2023.1270472. eCollection 2023.

Editorial: Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes

Giulio Frontino  1   2 , Elena Succurro  3   4 , Rosa Corcoy  5   6   7 , Francesco Scialabba  1   2 , Antonella Poloniato  8 , Marina Scavini  2
Affiliations
Editorial

Editorial: Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes

Giulio Frontino et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: diabetes; gestational diabetes (GDM); neonatal care; neonatal hypoglycemia; newborn; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Current and future trends in gestational diabetes diagnosis, care and neonatal outcomes

References

    1. Bashir M, Aboulfotouh M, Dabbous Z, Mokhtar M, Siddique M, Wahba R, et al. . Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study. J Maternal-Fetal Neonatal Med (2020) 33(14):2366–71. doi: 10.1080/14767058.2018.1550480 - DOI - PubMed
    1. Balsells M, García-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ (2015) 350:h102. doi: 10.1136/BMJ.H102 - DOI - PMC - PubMed
    1. Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: The offspring follow-up (MiG TOFU) - Body composition at 2 years of age. Diabetes Care (2011) 34(10):2279–84. doi: 10.2337/DC11-0660 - DOI - PMC - PubMed
    1. Paavilainen E, Tertti K, Nikkinen H, Veijola R, Vääräsmäki M, Loo B-M, et al. . Metformin versus insulin therapy for gestational diabetes: Effects on offspring anthropometrics and metabolism at the age of 9 years: A follow-up study of two open-label, randomized controlled trials. Diabetes Obes Metab (2022) 24(3):402–10. doi: 10.1111/DOM.14589 - DOI - PMC - PubMed
    1. Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PloS Med (2019) 16(8):e1002848. doi: 10.1371/JOURNAL.PMED.1002848 - DOI - PMC - PubMed

Publication types

LinkOut - more resources